Entasis Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ETTX and buy or sell other stocks, ETFs, and their options commission-free!About ETTX
Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.
CEOManoussos Perros, PhD
CEOManoussos Perros, PhD
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2015
Founded2015
Employees—
Employees—
ETTX Key Statistics
Market cap104.80M
Market cap104.80M
Price-Earnings ratio-1.95
Price-Earnings ratio-1.95
Dividend yield—
Dividend yield—
Average volume86.16K
Average volume86.16K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.88
52 Week high$3.88
52 Week low$1.40
52 Week low$1.40
Stock Snapshot
The current Entasis Therapeutics(ETTX) stock price is $2.19, with a market capitalization of 104.8M. The stock trades at a price-to-earnings (P/E) ratio of -1.95.
On 2025-12-18, Entasis Therapeutics(ETTX) stock opened at —, reached a high of —, and a low of —.
The Entasis Therapeutics(ETTX)'s current trading volume is 0, compared to an average daily volume of 86.16K.
In the last year, Entasis Therapeutics(ETTX) shares hit a 52-week high of $3.88 and a 52-week low of $1.40.
In the last year, Entasis Therapeutics(ETTX) shares hit a 52-week high of $3.88 and a 52-week low of $1.40.
People also own
Based on the portfolios of people who own ETTX. This list is generated using Robinhood data, and it’s not a recommendation.